false
0000945617
0000945617
2026-05-08
2026-05-08
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
FORM 8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): May 8, 2026
AMERICAN
CANNABIS COMPANY, INC.
(Exact
Name of Registrant as Specified in its Charter)
|
Delaware
(State or other jurisdiction of incorporation
or organization) |
Commission File Number
000-26108 |
90-1116625
(I.R.S. Employer
Identification Number) |
1004
S Tejon St Colorado Springs, CO 80903
(Address
of Principal Executive Offices and Zip Code)
(303) 974-4770
(Issuer's
telephone number)
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
[
] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[
] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[
] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[
] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities
registered pursuant to Section 12(b) of the Act:
| Title of Each Class |
Trading Symbols |
Name of Exchange on Which Registered |
| Common |
AMMJ |
None |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company [ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item
5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers.
On
May 8, Joe Cleghorn stepped down from his role as Chief Executive Officer of AMMJ (the “Company”). Mr. Cleghorn will
continue to serve the Company as Chairman of the Advisory Board, where he will provide strategic guidance and support to the
Company’s leadership team. The Board of Directors appointed James Woodend as the Company’s new Chief Executive Officer,
effective immediately. In addition, Mr. Woodend was appointed Chairman of the Board of Directors. The Company believes Mr.
Woodend’s leadership, operational experience, and strategic vision will support the Company’s continued growth and
long-term objectives. There were no disagreements between Mr. Cleghorn and the Company on any matter relating to the Company’s
operations, policies, or practices.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
AMERICAN
CANNABIS COMPANY, INC.
(Registrant)
By:
/s/ James Woodend
Name:
James Woodend
Date:
May 11, 2026
Title: CEO